Induced Pluripotent Stem Cells in Cardiovascular Medicine
Induced pluripotent stem (iPS) cells are generated by reprogramming human somatic cells through the forced expression of several embryonic stem (ES) cell-specific transcription factors. The potential of iPS cells is having a significant impact on regenerative medicine, with the promise of infinite s...
Saved in:
Main Authors: | Toru Egashira (Author), Shinsuke Yuasa (Author), Keiichi Fukuda (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2011-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Induced Pluripotent Stem Cell-Based Drug Screening by Use of Artificial Intelligence
by: Dai Kusumoto, et al.
Published: (2022) -
Future Prospects for Regenerated Heart Using Induced Pluripotent Stem Cells
by: Jun Fujita, et al.
Published: (2014) -
Toward the realization of cardiac regenerative medicine using pluripotent stem cells
by: Yoshikazu Kishino, et al.
Published: (2020) -
Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
by: Sho Tanosaki, et al.
Published: (2021) -
Nonhuman Primate Induced Pluripotent Stem Cells in Regenerative Medicine
by: Yuehong Wu, et al.
Published: (2012)